Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.

about

The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma.Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage.

P2860

Q50129161-B7F589A9-A317-4E13-AE30-F911D878BF32 Q53689677-C815169B-4F5F-47E8-8A19-3266CF881D69

P2860

Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.

Item

http://www.wikidata.org/entity/Q53133659

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.

@en

Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.

@nl

type

Item

label

Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.

@en

Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.

@nl

prefLabel

Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.

@en

Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.

@nl

P1476

Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.

@en

P2093

Feng Wang

http://www.w3.org/2001/XMLSchema#string

Hao Chen

http://www.w3.org/2001/XMLSchema#string

Libing Wang

http://www.w3.org/2001/XMLSchema#string

Luming Liu

http://www.w3.org/2001/XMLSchema#string

Peng Wang

http://www.w3.org/2001/XMLSchema#string

Ye Li

http://www.w3.org/2001/XMLSchema#string

Yongqiang Hua

http://www.w3.org/2001/XMLSchema#string

Zhen Chen

http://www.w3.org/2001/XMLSchema#string

Zhiqiang Meng

http://www.w3.org/2001/XMLSchema#string

Zhouyu Ning

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Cancer statistics, 2009

Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.

Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses.

Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas.

MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway.

miR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2.

MicroRNA-373 functions as an oncogene and targets YOD1 gene in cervical cancer.

Micro RNA-373 is down-regulated in pancreatic cancer and inhibits cancer cell invasion.

P304

95-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/CBM-170231

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28759959

http://www.w3.org/2001/XMLSchema#string

Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.

about

P2860

P2860

Low serum miR-373 predicts poor prognosis in patients with pancreatic cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698